CIK 0001104506 · Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- EIN
- 541972729
- Phone
- 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,737,650
- in 2 filings
Net −$3,737,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-04 | Lewis William Chair and CEO | Option exercise 10b5-1 | +6,259 | $30.46 | $191K | 307,444 |
| 2026-05-04 | Lewis William Chair and CEO | Option exercise 10b5-1 | +4,440 | $17.16 | $76K | 311,884 |
| 2026-05-04 | Lewis William Chair and CEO | Sale 10b5-1 | −433 | $134.18 | $58K | 311,451 |
| 2026-05-04 | Lewis William Chair and CEO | Sale 10b5-1 | −599 | $135.18 | $81K | 310,852 |
| 2026-05-04 | Lewis William Chair and CEO | Sale 10b5-1 | −5,318 | $137.01 | $729K | 305,534 |
| 2026-05-04 | Lewis William Chair and CEO | Sale 10b5-1 | −2,721 | $137.86 | $375K | 302,813 |
| 2026-05-04 | Lewis William Chair and CEO | Sale 10b5-1 | −1,247 | $139.09 | $173K | 301,566 |
| 2026-05-04 | Lewis William Chair and CEO | Sale 10b5-1 | −381 | $139.60 | $53K | 301,185 |
| 2026-05-04 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −6,259 | 31,296 | ||
| 2026-05-04 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −4,440 | 22,200 | ||
| 2026-04-16 | Lewis William Chair and CEO | Option exercise 10b5-1 | +6,259 | $30.46 | $191K | 307,444 |
| 2026-04-16 | Lewis William Chair and CEO | Option exercise 10b5-1 | +4,440 | $17.16 | $76K | 311,884 |
| 2026-04-16 | Lewis William Chair and CEO | Sale 10b5-1 | −2,246 | $142.99 | $321K | 309,638 |
| 2026-04-16 | Lewis William Chair and CEO | Sale 10b5-1 | −5,373 | $143.81 | $773K | 304,265 |
| 2026-04-16 | Lewis William Chair and CEO | Sale 10b5-1 | −2,255 | $144.66 | $326K | 302,010 |
| 2026-04-16 | Lewis William Chair and CEO | Sale 10b5-1 | −825 | $145.79 | $120K | 301,185 |
| 2026-04-16 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −6,259 | 37,555 | ||
| 2026-04-16 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −4,440 | 26,640 | ||
| 2026-04-06 | Lewis William Chair and CEO | Option exercise 10b5-1 | +6,259 | $30.46 | $191K | 307,444 |
| 2026-04-06 | Lewis William Chair and CEO | Option exercise 10b5-1 | +4,440 | $17.16 | $76K | 311,884 |
Page 5 of 23 · 448 trades